JSR hands over Crown to Carlyle-backed lab service company in $204M deal
JSR Life Sciences is parting ways with its CRO business Crown Bioscience, selling the unit to a Chinese clinical lab service provider in a deal valued at $204 million (PDF).…
Charles River lays off about 70 staffers in relocation as strategic shift begins
Charles River Laboratories is laying off staff at one of its East Coast sites just over a week after announcing a strategic shift that will also see the CRO giant…
BMS boosts cancer trials with Sarah Cannon’s clinical research platform
Bristol Myers Squibb is expanding a partnership with oncology organization Sarah Cannon Research Institute (SCRI), tapping into the institute’s community-based clinical trial network. BMS will plug its cancer pipeline into…
Charles River to cuts costs, shift direction as revenue slide continues
The board of Charles River Laboratories has completed a strategic review of the company, deciding to cut costs and shift investments into animal testing alternatives and other potential areas of…
Thermo Fisher adds clinical trial tech outfit Clario to goodie bag in $9B deal
Thermo Fisher Scientific is breaking out the big bills to score a clinical research treat. With $8.875 billion in cash, the life science giant is adding Clario Holdings to its…
Roche’s Flatiron Health expands blood cancer offerings with 6 new data sets
Cancer health tech company Flatiron Health has unveiled six new blood cancer data sets that together comprise information from more than half a million patient records, the Roche subsidiary announced…
WuXi AppTec sharpens focus by selling off China-based clinical research units
Chinese life science contracting giant WuXi AppTec is taking another step to zero in on its core offerings by hiving off two China-based subsidiaries. The Shanghai-based corporation announced on Oct.…
Psychiatrist launches new CRO with patient-centered focus
An experienced psychiatrist has launched a new contract research organization offering services ranging from preclinical research to clinical trial management. Headquartered in a Chicago suburb, LyfeSci Research & Innovation debuted…
Former FDA leader to chair Charles River advisory board on animal testing alternatives
As excitement around animal testing alternatives reaches a fever pitch, Charles River Laboratories is making a move to strengthen its development of new approach methodologies (NAMs) that can supplement or…
Almac makes $48M commitment to eClinical offering with new trial coordinator platform
CDMO conglomerate Almac is pouring $48 million into its eClinical offering via an investment that includes the launch of a new trial coordinator. The “first-in-class” platform will address the top…